Policies – Page 2 – media

Updated HIV Guidelines Recommend Immediate Treatment, Three-Drug Therapy

The 2018 Recommendations of the International Antiviral Society-USA (IAS-USA) suggests that early treatment in adult HIV patients brings about rapid and more definite decrease in viral load and better care of the patient.
- Source: MDEdge
- 792
- July 27, 2018
HIV Policies
HPV Vaccination for Both Girls & Boys

Government advisors are recommending that the national HPV immunization programme in England should include both boys and girls. The Joint Committee of Vaccinations and Immunisations (JCVI) believes that this would be a cost-effective option for preventing HPV-related diseases in boys and further improves public health.
- Source: PharmaTimes
- 683
- July 26, 2018
HPV vaccine Policies STD
Valsartan Based Drugs Recalled by FDA

At the beginning of this month, the U.S. Food and Drug Administration (FDA) announced to withdraw drugs containing valsartan, which treat high blood pressure and heart failure. The drugs were withdrawn due to the presence of N-nitrosodimethylamine (NDMA), which might lead to cancer.
- Source: HealthLine
- 880
- July 26, 2018
blood pressure cancer FDA heart failure Policies
AI Code of Conduct to be Laid Down by NHS Later in 2018

In the latter part of this year, a code of conduct for the use of artificial intelligence (AI) in healthcare will be introduced by the NHS, England, announced Harpreet Sood, associate CCIO at NHS England, at The King’s Fund’s Digital Health and Care Congress 2018 on 11 July.
- Source: DigitalHealth.net
- 905
- July 24, 2018
AI NHS Policies
US Prison Inmates with Hepatitis C Devoid of Treatment

Reports reveal that as many as 144,000 inmates of state prisons in the United States who have hepatitis C are not being given any kind of treatment. Corrections departments in every state were enquired about the number of inmates with hepatitis C, the treatment they were receiving, the drugs used for their treatment and also about policies that exist which concern inmates inflicted with the virus.
- Source: Speciality Pharmacy Times
- 658
- July 11, 2018
hepatitis C Policies
China’s Drastic Reduction in Cancer Drug Price

The newly formed health insurance administration in China intend to deepen discounts on cancer drugs which were already on its National Reimbursement Drug List (NRDL) based on public bidding and procurement based on cancer therapies. In the meantime, officials will start enlisting negotiations for treatments which were not included on the coverage list.
- Source: FiercePharma
- 839
- July 11, 2018
cancer China pharmaceutical drugs Policies
DHA Announces Free Hepatitis C Screening & Treatment in Dubai

Hepatitis C is caused by the Hepatitis C virus (HCV), which affects the liver. The World Health Organization (WHO) reported that around 399,000 people die every year due to Hepatitis C throughout the world. Hepatitis C leads to cirrhosis and liver cancer since it is diagnosed only at a late stage.
- Source: GulfNews
- 783
- July 10, 2018
hepatitis C Market Views Policies UAE
FDA Rebukes Chinese API maker Sichuan Friendly Pharmaceutical in Warning Letter

The FDA sent a warning letter to Sichuan Friendly Pharmaceutical after listing it in the import alert list due to its abysmal performance during a fall inspection. The FDA was not pleased with the manufacturing methods it saw at the Chinese API maker’s facility.
- Source: FiercePharma
- 752
- July 9, 2018
FDA pharmaceutical company Policies
Cost Effective Universal Screening Aids in Eliminating Hepatitis C

In response to the issue, the scientific team of Professor Yazdan Yazdanpanah's Inserm and Sylvie Deuffic-Burban created a mathematical model to estimate the efficiency and cost-effectiveness of varied screening strategies which includes universal screening.
- Source: News Medical
- 815
- July 6, 2018
blood test hepatitis C Policies
Indian Government to Ban Oxycontin Imports

After months of inspections, Indian Ministry of Health and Family Welfare have taken a decision to ban the import of Oxytocin in India from 1 July 2018. The government has restricted private manufactures to produce Oxytocin formulations for domestic use, only state-owned Karnataka Antibiotics & Pharmaceuticals Ltd. (KAPL) have been allowed to manufacture and directly supply to registered hospitals and clinics across India.
- Source: SputnikNews
- 659
- June 29, 2018
India oxytocin pharmaceutical drugs Policies

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.